Dr. Kenneth Bloom: Biomarker Testing in Oncology―Where We Are and Where We're Headed
Dr. Kenneth Bloom: Biomarker Testing in Oncology―Where We Are and Where We're Headed
Interview by L Scott Zoeller
20100613
2010 Jul 13
OncologySTAT Editorial Team
Dr. Kenneth Bloom: Biomarker Testing in Oncology―Where We Are and Where We're Headed
OncologySTAT Editorial Team. 2010 Jul 13, Interview by L Scott Zoeller
Dr. Kenneth Bloom has spent more than two decades serving in senior academic, consultative, and clinical roles with leading hospitals and health care enterprises. He was Associate Professor of Pathology at Rush Medical College in Chicago and is a researcher and lecturer in the fields of pathology and cancer-related topics. Dr. Bloom is currently Chief Medical Officer of Clairent, Inc. For more information, view his profile. Advances in biomarker analysis have brought cancer diagnosis and classification...